TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +383.5% | -103.1% | – | – | -112.1% | – | |
| – | +51.2% | -16.8% | -17.0% | -22.2% | -8.8% | +51.4% | -11.9% | -31.4% | -32.4% | +94.2% | +144.9% | – | |
| – | -7.0% | -10.2% | +2.8% | -7.7% | +17.4% | -16.3% | -6.8% | +0.7% | -2.1% | +0.5% | +33.0% | – | |
| – | – | – | -34.6% | -112.7% | – | +274.0% | +203.8% | -110.7% | – | -71.0% | -202.5% | – | |
| – | +3,123.8% | -86.6% | -60.4% | -58.3% | +1,166.7% | -100.0% | – | -100.0% | – | -100.0% | – | – | |
| – | +3,123.8% | – | -117.8% | +474.0% | – | +95.3% | -218.4% | +176.5% | – | +8,844.4% | -214.8% | – | |
| – | -2.0% | -94.4% | -73.0% | -14.3% | +33.0% | +65.5% | -42.4% | +34.8% | +191.9% | +194.0% | – | – | |
| – | -2.5% | -94.4% | -97.4% | +745.5% | -1.9% | +134.0% | -41.1% | -20.5% | +272.8% | +274.0% | – | – | |
| – | – | – | -152.4% | – | – | +405.0% | +135.3% | -162.5% | – | – | -153.8% | – | |
| – | – | – | – | – | – | – | +383.4% | -103.1% | – | – | -112.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.